Cardoso V, Bistaffa M, Sterman R, Lima L, Toldo G, Cancino-Bernardi J
ACS Appl Mater Interfaces. 2025; 17(9):13197-13220.
PMID: 40045524
PMC: 11891907.
DOI: 10.1021/acsami.4c16840.
Browne I, Patel Y, Hanna N, Haider E, Hanna W
JTCVS Tech. 2025; 29:150-160.
PMID: 39991293
PMC: 11845381.
DOI: 10.1016/j.xjtc.2024.10.024.
Zhao J, Dai J, Zhou N, Liu D, Wang D, Miao S
Genes Genomics. 2025; .
PMID: 39976649
DOI: 10.1007/s13258-025-01623-0.
Gao G, Zhang X
Front Immunol. 2025; 16:1542844.
PMID: 39917300
PMC: 11799241.
DOI: 10.3389/fimmu.2025.1542844.
Gong W, Vaishnani D, Jin X, Zeng J, Chen W, Huang H
BMC Cancer. 2025; 25(1):10.
PMID: 39754166
PMC: 11697834.
DOI: 10.1186/s12885-024-13402-3.
Hyaluronic acid-targeted topotecan liposomes improve therapeutic efficacy against lung cancer in animals.
Xue G, Tang L, Pan X, Li S, Zhao J
Front Oncol. 2024; 14:1520274.
PMID: 39737406
PMC: 11682985.
DOI: 10.3389/fonc.2024.1520274.
enhances the development of lung adenocarcinoma by regulating the glycolysis pathway.
Wang L, Xie X
Oncol Res. 2024; 33(1):123-132.
PMID: 39735672
PMC: 11671407.
DOI: 10.32604/or.2024.048562.
Detection, measurement, and diagnosis of lung nodules by ultra-low-dose CT in lung cancer screening: a systematic review.
Pan Z, Zhang Y, Zhang L, Wang L, Zhao K, Li Q
BJR Open. 2024; 6(1):tzae041.
PMID: 39665102
PMC: 11634541.
DOI: 10.1093/bjro/tzae041.
Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR-TKIs Resistance.
Tian J, Shi Z, Zhao L, Liu P, Sun X, Long L
Clin Respir J. 2024; 18(12):e70037.
PMID: 39631794
PMC: 11617040.
DOI: 10.1111/crj.70037.
Forkhead box N1 is possibly a novel biomarker and prognostic indicator for patients with squamous cell lung carcinoma.
Wang X, Zhang C, Duan B, Bai J, Li T, Dong X
Int J Med Sci. 2024; 21(15):3058-3068.
PMID: 39628682
PMC: 11610332.
DOI: 10.7150/ijms.104616.
Two-Year Experience of a Center of Excellence for the Comprehensive Management of Non-Small Cell Lung Cancer at a Fourth-Level Hospital in Bogota, Colombia: Observational Case Series Study and Retrospective Analysis.
Garcia-Herreros L, Rico-Rivera E, Garcia Morales O
J Clin Med. 2024; 13(22).
PMID: 39597963
PMC: 11594720.
DOI: 10.3390/jcm13226820.
Effect of Exercise and Pulmonary Rehabilitation in Pre- and Post-Surgical Patients with Lung Cancer: Systematic Review and Meta-Analysis.
Cruz Mosquera F, Murillo S, Naranjo Rojas A, Perlaza C, Castro Osorio D, Liscano Y
Medicina (Kaunas). 2024; 60(11).
PMID: 39596911
PMC: 11595816.
DOI: 10.3390/medicina60111725.
Differential Radiomics-Based Signature Predicts Lung Cancer Risk Accounting for Imaging Parameters in NLST Cohort.
Ebrahimpour L, Despres P, Manem V
Cancer Med. 2024; 13(20):e70359.
PMID: 39463128
PMC: 11513548.
DOI: 10.1002/cam4.70359.
Progression in Near-Infrared Fluorescence Imaging Technology for Lung Cancer Management.
Chen X, Li Y, Su J, Zhang L, Liu H
Biosensors (Basel). 2024; 14(10).
PMID: 39451714
PMC: 11506746.
DOI: 10.3390/bios14100501.
Functional status in patients undergoing lung resection.
Macounova P, Bobcikova K, Tomaskova H, Mittak M, Argalasova L
Arch Med Sci. 2024; 20(4):1339-1344.
PMID: 39439689
PMC: 11493037.
DOI: 10.5114/aoms/190516.
COX-2 in lung cancer: Mechanisms, development, and targeted therapies.
Liu X, Zhang J, Sun W, Cao J, Ma Z
Chronic Dis Transl Med. 2024; 10(4):281-292.
PMID: 39429482
PMC: 11483542.
DOI: 10.1002/cdt3.120.
ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway.
Zhai W, Yang W, Ge J, Xiao X, Wu K, She K
Biol Direct. 2024; 19(1):94.
PMID: 39415271
PMC: 11483991.
DOI: 10.1186/s13062-024-00512-y.
Three-Dimensional-Bioprinted Non-Small Cell Lung Cancer Models in a Mouse Phantom for Radiotherapy Research.
Mei Y, Lakotsenina E, Wegner M, Hehne T, Krause D, Hakimeh D
Int J Mol Sci. 2024; 25(19).
PMID: 39408596
PMC: 11476964.
DOI: 10.3390/ijms251910268.
Empowering minoritized Alabamians screened for lung cancer-The Alabama Lung Cancer Awareness Screening and Education (ALCASE) project.
Niranjan S, Tipre M, Hardy C, Bowman T, Baskin M
Cancer Med. 2024; 13(19):e70213.
PMID: 39400521
PMC: 11472649.
DOI: 10.1002/cam4.70213.
Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression.
Shen Y, Han R, Yu X, Mao J
J Cardiothorac Surg. 2024; 19(1):549.
PMID: 39342367
PMC: 11437964.
DOI: 10.1186/s13019-024-03075-1.